PARP inhibitors in platinum sensitive relapsed ovarian cancer – where are we now and where are we going?

E-session 419000 / Sponsored / NO CME Add to My Agenda

Expert:

Nicoletta Colombo, expert of session 'PARP inhibitors in platinum sensitive relapsed ovarian cancer – where are we now and where are we going?'

Nicoletta Colombo
European Institute of Oncology
Milan, Italy

Discussant: Bradley J. Monk, Professor, Gynecologic Oncology: University of Arizona and Creighton University
Arizona Oncology (US Oncology Network), Phoenix, AZ, USA

Session held in collaboration with AstraZeneca

View slides

Enter the recorded session

Share on:

In order to access to the CME test, please check the minimum system requirements.
If the WebEx platform is used in temporary mode, access to the CME test can not be guaranteed

Check the minimum system requirements

06
Dec 2017
18:15-19:00 CET

Top